These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28337777)

  • 41. Syringocystadenoma papilliferum: report of 8 cases.
    Rammeh-Rommani S; Fezaa B; Chelbi E; Kammoun MR; Ben Jilani SB; Zermani R
    Pathologica; 2006 Jun; 98(3):178-80. PubMed ID: 17036946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metastatic Syringocystadenocarcinoma Papilliferum: A Case Report, Tumor Genomic Profiling, and Literature Review.
    Altunel E; Perepletchikov A; Kozyreva O
    Case Rep Oncol Med; 2020; 2020():9056209. PubMed ID: 32850165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poromas with large lumens histopathologically mimicking syringocystadenoma papilliferum: Report of three cases.
    Arakawa H; Tanese K; Miura K; Ebata S; Yamada D; Masui Y; Tanaka M; Saida T; Ansai SI
    Australas J Dermatol; 2019 Feb; 60(1):e51-e55. PubMed ID: 29943807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature.
    Halsey JN; Faith EF; Logan SJ; Shenoy A; Schieffer KM; Cottrell CE; Lillis AP; Aldrink JH; Setty BA; Pearson GD
    Case Rep Dermatol Med; 2022; 2022():8076649. PubMed ID: 35154835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Syringocystadenocarcinoma papilliferum with locoregional metastases.
    Satter E; Grady D; Schlocker CT
    Dermatol Online J; 2014 Apr; 20(4):22335. PubMed ID: 24746298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Syringocystadenoma Papilliferum in Coexistence With Verrucous Carcinoma on the Face.
    Park JH; Kim BY; Shin JJ; Kim IH
    Dermatol Surg; 2018 Aug; 44(8):1144-1146. PubMed ID: 29112527
    [No Abstract]   [Full Text] [Related]  

  • 48. Syringocystadenoma papilliferum with coexisting hydrocystoma.
    Keyal U; Bhatta AK; Liu Y
    Indian J Dermatol Venereol Leprol; 2019; 85(2):236. PubMed ID: 29536975
    [No Abstract]   [Full Text] [Related]  

  • 49. Grouped apocrine gland component associated with sporadic syringocystadenoma papilliferum: A case report and BRAFV600E mutation analysis of the two components.
    Mitsui Y; Ogawa K; Takeda M; Kuwahara M; Fukumoto T; Asada H
    J Dermatol; 2019 Nov; 46(11):e395-e398. PubMed ID: 31294472
    [No Abstract]   [Full Text] [Related]  

  • 50. Solitary syringocystadenoma papilliferum on the face: A rare case report with dermoscopic findings.
    Chen J; Chen Q; Zhu H
    Australas J Dermatol; 2020 Feb; 61(1):e116-e117. PubMed ID: 31573674
    [No Abstract]   [Full Text] [Related]  

  • 51. Cutaneous apocrine carcinoma in groin with bilateral lymph node metastasis: a case report and review of the literature.
    Guo J; Wu G; Xu J; Ma Z; Zhou Z
    Int J Clin Exp Pathol; 2014; 7(11):8266-70. PubMed ID: 25550884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Syringocystadenoma papilliferum: Unusual location.
    Elfatoiki F; Khadir K; Ouakadi A; Azzouzi S; Bahechar N; Benchikhi H
    Dermatol Online J; 2011 Jun; 17(6):7. PubMed ID: 21696687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient.
    Zilberg C; Paver E; Damian D
    Case Rep Dermatol; 2022; 14(2):127-131. PubMed ID: 35813836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Syringocystadenocarcinoma Papilliferum In Situ-Like Changes in Extramammary Paget Disease: A Report of 11 Cases.
    Konstantinova AM; Kacerovska D; Stewart CJ; Szepe P; Pitha J; Sulc M; Bencik V; Michal M; Shideler B; Kerl K; Kazakov DV
    Am J Dermatopathol; 2016 Dec; 38(12):882-886. PubMed ID: 26863065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Syringocystadenoma papilliferum].
    El Makrini NI; Kissou A; Benzekri L; Senouci K; Hassam B
    Presse Med; 2019 Nov; 48(11 Pt 1):1349-1350. PubMed ID: 31732362
    [No Abstract]   [Full Text] [Related]  

  • 56. An Unusual Case of Syringocystadenocarcinoma Papilliferum In Situ With Macular Amyloidosis.
    Singh S; Khullar G; Sharma T; Elhence P
    JAMA Dermatol; 2017 Jul; 153(7):725-727. PubMed ID: 28423161
    [No Abstract]   [Full Text] [Related]  

  • 57. Unusual congenital syringocystadenoma papilliferum on the scalp presenting as only erosion at birth.
    Sho Y; Sakai T; Yamate T; Nakamura Y; Saito-Shono T; Shimada H; Takeo N; Uehara M; Shimizu F; Nishida H; Hatano Y
    Eur J Dermatol; 2020 Apr; 30(2):198-199. PubMed ID: 32538363
    [No Abstract]   [Full Text] [Related]  

  • 58. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
    Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
    J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pathologic diagnosis and differential diagnosis of low-grade adenosquamous carcinoma of breast and syringomatous adenoma of nipple].
    Li J; Yang GZ; Jin H; Ding HY
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):301-4. PubMed ID: 22883667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hidradenoma Papilliferum With Oncocytic Metaplasia: A Histopathological and Immunohistochemical Study.
    Elbendary A; Cochran E; Xie Q; Kabigting F; Pereira L; Elston DM; Heilman E
    Am J Dermatopathol; 2016 Jun; 38(6):444-7. PubMed ID: 27097337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.